SCLX Q2 2021 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$72M

Q2 2021 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$9M+56.5% YoY

Gross Profit

$9M94.3% margin

Operating Income

-$7M-73.0% margin

Net Income

-$15M-166.8% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+67.0%

Cash Flow

Operating Cash Flow

-$57,359

Free Cash Flow

-$57,360

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$140M

Total Liabilities

$9M

Stockholders' Equity

$131M

Cash & Equivalents

$257,621

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$6M	+56.5%
Gross Profit	$9M	$5M	+62.3%
Operating Income	-$7M	-$9M	+23.6%
Net Income	-$15M	-$12M	-29.4%